The Chronic Overlapping Pain Condition Screener.
Andrew Schrepf, William Maixner, Roger Fillingim...
https://pubmed.ncbi.nlm.nih.gov/37633574/Actively Recruiting
Led by Vanderbilt University Medical Center · Updated on 2026-01-21
220
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are studying a condition called interstitial cystitisbladder pain syndrome ICBPS, which causes severe pain and affects millions in the United States. This condition is difficult to treat because symptoms vary widely, and emotional distress can worsen physical pain. The study aims to understand how different types of ICBPS pain, or phenotypes, affect responses to two common therapies pelvic floor physical therapy and cognitive-behavioral therapy CBT. This research hopes to tailor treatments based on individual pain patterns for better care in the future. The study compares two treatment approaches for ICBPS. One group receives pelvic floor physical therapy involving 10 weekly 45-minute sessions with a trained physical therapist, focusing on manual techniques to ease muscle tension and reduce symptoms. The other group receives psychosocial treatment with 8 weekly 50-minute individual visits with a trained therapist, covering pain coping, relaxation, education, and communication skills. These therapies are given in separate periods, and the study uses random assignment to place participants in one of these treatments. Participants will be involved in individual therapy or physical therapy sessions each week for 8 to 10 weeks. Researchers will assess treatment response using the Global Response Assessment scale shortly after therapy ends. Additional tests will measure pain sensitivity, nerve growth factors, and inflammatory markers before, after, and six months following treatment. The study also monitors emotional and physical health throughout. Overall participation lasts several months, including follow-up visits to understand long-term effects and treatment outcomes.
CONDITIONS
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
L
Lindsey McKernan, PhD, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Vanderbilt University Medical Center
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Psychosocial Self-Management | Pelvic Floor Physical Therapy |
|---|---|---|
| What it is | An individualized psychosocial self-management program involving 8 weekly sessions with a trained therapist, addressing pain coping, relaxation, education about IC/BPS, and communication strategies. | A physical therapy protocol with 10 weekly sessions focused on manual manipulation to release pelvic muscle tension, trigger points, and connective tissue, using both internal and external techniques. |
| Role in trial | Serves as the experimental arm, evaluating effects of psychosocial self-management in the target population. | Acts as the active comparator arm, reflecting a recognized treatment used in clinical practice for IC/BPS. |
| Primary use | Aims to improve pain coping, relaxation, and self-management of IC/BPS symptoms through therapeutic education and skills training. | Targets pain and urgency symptoms by reducing pelvic floor muscle tension and trigger points, improving physical function and symptom management. |
| How it is given or performed | Eight weekly, 50-minute individual therapy sessions delivered by trained therapists using a structured protocol, tailored to the patient's needs. | Ten weekly, 45-minute sessions with a physical therapist applying external and internal manual techniques to pelvic and related muscle groups. |
| Evidence status | Ongoing clinical investigation; published evidence for structured psychosocial interventions in IC/BPS remains limited, and results for this specific protocol are not yet established. | Pelvic floor physical therapy is recommended by clinical guidelines as a current treatment for IC/BPS, with supportive published evidence and established clinical use. |
| Important limitations | Effectiveness depends on individual engagement, session attendance, and underlying psychological stability; published evidence in IC/BPS is limited and trial outcomes are pending. | Requires regular in-person visits and trained therapists familiar with IC/BPS; not all patients may tolerate internal techniques. Accessibility may vary, and guideline evidence notes these practical limitations. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 8 to 10 weeks
Participants receive either psychosocial self-management therapy or pelvic floor physical therapy. Psychosocial therapy includes 8 weekly 50-minute individual sessions with a trained therapist focusing on pain coping, relaxation, education, and communication. Pelvic floor physical therapy includes 10 weekly 45-minute individual sessions with a trained physical therapist using manual techniques to relieve muscle tension and reduce symptoms.
8 weekly visits for psychosocial therapy or 10 weekly visits for pelvic floor physical therapy
Duration - Up to 16 weeks after treatment
Participants are monitored for outcomes and changes after completing treatment, including assessments at Week 24.
1 visit at Week 24 (in-person)
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Andrew Schrepf, William Maixner, Roger Fillingim...
https://pubmed.ncbi.nlm.nih.gov/37633574/Amanda L Sherman, Matthew C Morris, Stephen Bruehl...
https://pubmed.ncbi.nlm.nih.gov/25967582/Miriam O Ezenwa, Robert E Molokie, Zaijie Jim Wang...
https://pubmed.ncbi.nlm.nih.gov/25581383/Jun Li, Donald A Simone, Alice A Larson
https://pubmed.ncbi.nlm.nih.gov/9928779/M E Shy, E M Frohman, Y T So...
https://pubmed.ncbi.nlm.nih.gov/12654951/Emmanouil Rampakakis, Peter A Ste-Marie, John S Sampalis...
https://pubmed.ncbi.nlm.nih.gov/26535150/Angela R Starkweather, Amy Heineman, Shannon Storey...
https://pubmed.ncbi.nlm.nih.gov/26856520/Philip M Hanno, David Allen Burks, J Quentin Clemens...
https://pubmed.ncbi.nlm.nih.gov/21497847/Vanderbilt University Medical Center
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor